Skip to content

Clinical study of treatment for depressed lesions using cultured adipose derived stem cells.

Clinical study of treatment for depressed lesions using cultured adipose derived stem cells. - Clinical study of treatment for depressed lesions using cultured adipose derived stem cells.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020530
Enrollment
11
Registered
2016-01-12
Start date
2016-01-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressed lesion

Interventions

After a small amount of fat is harvested from the patient, adipose derived stem cells (ADSCs) is extracted at Cell Processing Center. The ADSCs are cultured and injected into the depressed lesion with

Sponsors

University of the Ryukyus Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)patients with congenital or acquired depressed lesion in which fat grafting is suggested. (Breast deficit after breast cancer, traumatic tissue defects, hemifacial atrophy, facial muscle atrophy after facial palsy, enophthalmos due to anophthalmia, funnel chest, etc.) 2)patients with depressed lesion who undergo secondary revision surgery with fat grafting. 3)In case of secondary revision surgery, at least three months should be passed after first surgery. 4)Informed consent should be obtained. 5)patients must be at least 10 years old without serial illness. 6)patients who live in Okinawa prefecture at least 6 months after the clinical study. 7)patients who undergo another clinical study 'Development of extraction system of safe and good quality adipose derived stem cells' may be included if they qualify above mentioned inclusion criteria.

Exclusion criteria

Exclusion criteria: 1)pregnant patients. 2)patients with the risk of recurrence or metastasis of malignant tumor 3)patients who take anti-cancer agent or immunosuppressive agent 4)patients with local infection in or near the depressed lesion.

Design outcomes

Primary

MeasureTime frame
Standardized photograph will be taken to assess the change the recovery rate of depressed lesion. Time points will be pre-treatment, 1 week, and 1,3,6 months after the treatment. Also, computed tomography scan will be taken to assess the volumetric change pre- and post 6 months operatively.

Secondary

MeasureTime frame
Graft survival rate. Calcification and cyst formation. Severity, date, frequency, duration, incidence rate and attribution of adverse events.

Countries

Japan

Contacts

Public ContactYusuke Shimizu

University of the Ryukyus Hospital Department of Plastic and Reconstructive Surgery

yyssprs@med.u-ryukyu.ac.jp0988953331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026